YAP1 and cancer: Specifically, elevated YAP/TAZ expression levels caused by somatic copy number alterations (SCNAs) were selected with a strong preference in their models of squamous-cell-involved cancer, supporting YAP/TAZ amplification as a key driver of these cancer types.